The interest in Cannabis sativa L. phytocomplex as a medicinal tool is a recently-emerging topic. Neurodegenerative diseases represent a promising field of application for cannabis and its preparations, as most of this pathologic conditions relies on an inflammatory etiology. Several cannabis constituents display anti-inflammatory effects targeting multiple pathways. In this review, a comprehensive overview of the available literature on C sativa constituents activities in neuroinflammation is given. On the basis that the anti-inflammatory activity of cannabis is not attributable to only a single constituent, we discuss the possible advantages of administering the whole phytocomplex in order to fully exploit the “entourage effect” in neuroinflammatory-related conditions.

Borgonetti, V., Governa, P., Montopoli, M., Biagi, M. (2019). Cannabis sativa L. constituents and their role in neuroinflammation. CURRENT BIOACTIVE COMPOUNDS, 15(2), 147-158 [10.2174/1573407214666180703130525].

Cannabis sativa L. constituents and their role in neuroinflammation

Governa, Paolo
;
Biagi, Marco
Writing – Review & Editing
2019-01-01

Abstract

The interest in Cannabis sativa L. phytocomplex as a medicinal tool is a recently-emerging topic. Neurodegenerative diseases represent a promising field of application for cannabis and its preparations, as most of this pathologic conditions relies on an inflammatory etiology. Several cannabis constituents display anti-inflammatory effects targeting multiple pathways. In this review, a comprehensive overview of the available literature on C sativa constituents activities in neuroinflammation is given. On the basis that the anti-inflammatory activity of cannabis is not attributable to only a single constituent, we discuss the possible advantages of administering the whole phytocomplex in order to fully exploit the “entourage effect” in neuroinflammatory-related conditions.
2019
Borgonetti, V., Governa, P., Montopoli, M., Biagi, M. (2019). Cannabis sativa L. constituents and their role in neuroinflammation. CURRENT BIOACTIVE COMPOUNDS, 15(2), 147-158 [10.2174/1573407214666180703130525].
File in questo prodotto:
File Dimensione Formato  
2019_Cannabis_CBC.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 760.44 kB
Formato Adobe PDF
760.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1073165